I-CHENGDU, ECHINA / ACCESSWIRE / Agasti 20, 2021 / "Umgubho Weminyaka engama-26 ka-Deebio Wokuthekelisa E-Japan" wabanjwa ngempumelelo e-Chengdu, e-China, ngoMashi 29. USolwazi u-Yu Rong, uMqondisi woMnyango we-Biotechnology and Pharmacology we-West China School of Pharmacy, Sichuan University, Dr. Tang Can, Associate Professor of the School of Biological Sciences and Technology of Chengdu Medical College, kanye noMnu. Tan Ting, General Manager Beijing Minkang Pharmaceutical Technology Co., Ltd., bahambele umgubho.
Kusukela yasungulwa ngo-1994, iSichuan Deebio Pharmaceutical Co., Ltd. (ngemuva kwalokhu ebizwa ngokuthi i-Deebio) igxile emakethe yezinto ezibonakalayo ze-bio-enzyme.U-Deebio usethuthuke waba umholi wemboni yomhlaba wonke ovela efektri encane yesifunda.Ngokusizakala ngokukhiqizwa kwayo kwe-bio-enzyme yemvelo ehamba phambili emhlabeni namandla e-R&D, imikhiqizo yayo idayiswa emazweni angaphezu kwama-30 emhlabeni jikelele, enesabelo semakethe esikhulu kunazo zonke somhlaba wonke ngezinhlobo zayo eziningi zemikhiqizo.Ngeminyaka eminingi yokuzikhandla kodwa ukukhangisa okuncane, u-Deebio usephenduke "ingqwele efihliwe" esezingeni eliphansi futhi esebenzayo embonini.
ISIKHANGISO
Ukugcina Ikhwalithi Ephezulu kanye Nokuhola Imakethe Yomhlaba Wonke
"Ikhwalithi iyimpilo kaDeebio," kusho uZhang Ge, uSihlalo weBhodi kanye noMongameli we-Deebio, engxoxweni.
Imikhiqizo ye-Deebio's bio-enzyme API isifinyelele emazingeni aphezulu kakhulu emhlabeni.Imikhiqizo inomsebenzi ophezulu, ukuhlanzeka okuphezulu, nokuzinza okuphezulu, ehlangabezana nezicaciso zemikhiqizo eyahlukene yozakwethu.Imikhiqizo yekhwalithi ephezulu ayizuzanga kuphela isitifiketi se-GMP e-China kanye ne-EU-GMP e-Europe, kodwa iphinde yaphumelela ukuhlolwa kwe-Sanofi, i-Celltrion, ne-Nichi-Iko.
Imizamo engapheli yekhwalithi ephezulu ilethe i-Deebio imakethe ebanzi.Ezinsukwini zokuqala zokusungulwa kwayo, i-Deebio yaba ukuphela komphakeli womhlaba wonke we-kallidinogenase engahluziwe yozakwethu baseJapane abanekhwalithi ezinzile, isevisi ecabangelayo kanye nesithunzi esihle.Njengamanje, i-kallidinogenase ngokuyisisekelo ithatha imakethe kazwelonke.I-Deebio isibe umphakeli omkhulu we-pancreatin emhlabeni;amasheya emakethe e-pepsin, i-trypsin-chymotrypsin neminye imikhiqizo yonke idlula ama-30%;I-Deebio futhi ukuphela komnikezeli we-elastase, i-pepsin yesixazululo esicacile kanye ne-High Lipase Pancreatin APIs emakethe yomhlaba.Izinkampani zemithi ezidume umhlaba wonke njenge-Sanofi, i-Celltrion kanye ne-Nichi-Iko zisungule ubudlelwano besikhathi eside nobuzinzile no-Deebio.
“Siyakwazisa ukwenza kahle kwenkampani yakho ngekhwalithi kanye nokuqondisisa okujulile ngemakethe yomkhiqizo.Ungumnikezeli we-API omuhle kakhulu. "Uzakwethu waseJapan ka-Deebio u-Tohri & Company Ltd naye uzwakalise ukuqaphela kwakhe u-Deebio encwadini yakhe yokuhalalisela.
Ukutshalwa Kwezimali Okuqhubekayo Ukuze Kuzuzwe Intuthuko Esezingeni Eliphezulu
ISIKHANGISO
NgokukaZhang Ge, ikhwalithi yomkhiqizo izoba yinto ehamba phambili ekutholeni isisekelo emkhakheni we-API we-bio-enzyme womhlaba.Ukuqinisekisa izinga eliphezulu lemikhiqizo, akwanele ukuthembela ngokuphelele ezimalini noma entshisekweni.Kuyadingeka ukutshala imali njalo kwezobuchwepheshe, ukuphatha nengqalasizinda.Yilokhu kanye uDeebio akwenzayo.
Okokuqala, ukutshalwa kwezimali kwezobuchwepheshe.Ukuze kuthuthukiswe izinga lokuphatha lobuchwepheshe, ngo-2003, u-Deebio wasungula ibhizinisi elihlanganyelwe elibizwa ngokuthi i-Deyang Sinozyme Pharmaceutical Co., Ltd. ngokuhlanganyela nozakwethu waseJalimane owayenobuchwepheshe obungcono namandla okuphatha.Phakathi neminyaka engu-18 yokubambisana, uzakwethu waseJalimane ubevame ukuvakashela i-Deebio ukuze anikeze isiqondiso nokuqondisa, ethula izindlela zokuphatha isistimu yekhwalithi ethuthukisiwe ku-Deebio, ukuze akhuphule amandla okuphatha uhlelo lwekhwalithi ka-Deebio ezingeni eliphezulu kakhulu lamazwe ngamazwe.
Ngaphezu kwalokho, u-Deebio uyaqhubeka nokutshala imali ocwaningweni lwezobuchwepheshe.Ngo-1997, lapho i-Deebio ikwazi ukulondoloza ukusebenza kwayo okujwayelekile, yaqala ukuthuthukisa ukubambisana okuseduze kocwaningo lwemboni-yunivesithi namanyuvesi nezikhungo zocwaningo, okuhlanganisa i-Tsinghua University, i-Chinese Academy of Sciences, i-Sichuan University, i-China Pharmaceutical University, njll.
Ngeminyaka yokuhlangenwe nakho kwezobuchwepheshe, u-Deebio udale ukuvikelwa komsebenzi we-enzyme yenqubo egcwele, ukusebenza okungabhubhisi kanye nobuchwepheshe obunembile bokuhlanza, okukhiqiza umsebenzi ophezulu, ukuhlanzeka okuphezulu kanye nokuzinza okuphezulu kwe-bio-enzymes.Ngaphezu kwalokho, u-Deebio unekhono kakhulu futhi unolwazi kubuchwepheshe benqubo yokuhlanza izinto eziphilayo futhi ngaleyo ndlela ukwazi ukuthuthukisa ngokushesha imikhiqizo emisha futhi azuze ukukhiqizwa ngobuningi.
Okwesibili, ukutshalwa kwezimali kwabaphathi.Ukukhiqizwa kwe-Deebio nokuphathwa kwekhwalithi kulandela ngokuqinile uhlelo lokuphatha lwe-GMP lwaseYurophu.Futhi inamakhono okuphatha uhlelo lwekhwalithi ye-US FDA, Japan PMDA, kanye ne-South Korea MFDS.
Okwesithathu, ukutshalwa kwezimali kwehadiwe yokukhiqiza.Ngo-2003, lapho kwakungenzeka ukwakha ifektri nge-5 million yuan, u-Deebio watshala imali izikhathi ezingu-4 ukuze akhe imboni ye-Sinozyme.Ngo-2012, yaphinde yatshala imali ekwakhiweni kwefekthri yezemithi i-Deebio.Namuhla, i-Deebio ineworkshops ze-GMP ezi-4 ezinemishini ethuthukisiwe, njengesistimu eqhubekayo yokuhlukanisa ezenzakalelayo evaliwe kanye nesistimu ye-chromatography ehambisanayo ezenzakalelayo.Iphinde yatshala imali ekwakhiweni kwesikhungo sokuhlanza amanzi angcolile “sesitayela sengadi” esinamandla okuhlanza nsuku zonke angu-1,000m³, esiphumelele ukuhlolwa kwe-EHS kwezinkampani ezidumile emhlabeni jikelele.I-Deebio manje isingomunye wabakhiqizi abakhulu be-API be-bio-enzyme e-China.
Ukuqongelela okuqhubekayo phakathi namashumi eminyaka kudale umgoqo wokuncintisana we-Deebio ongenakudlulwa ontanga yakhe.
Ukuthuthukiswa Okuqhubekayo Ukuze Kuthuthukiswe Ukuthuthukiswa Kwemboni
Ukufunda njalo kuwukhiye wobuholi besikhathi eside bemboni ka-Deebio.I-Deebio ayiqhubeki nje nokuvuselela nokwakha izimboni kodwa futhi iqala ukuthuthukisa ukuphathwa kwebhizinisi kanye nokuqinisa ukwakhiwa kwekhono lekhono.Ishabhu ye-GMP kaDeebio, eyakhiwe ngokuhambisana namazinga e-FDA, yafakwa ngokusemthethweni ekukhiqizweni ngoJuni.Ngosizo lwe-Sunsoar Strategy Consulting Company, isu lebhizinisi lika-Deebio nalo selithuthukisiwe.Eminyakeni yamuva nje, u-Deebio ubelokhu enza imizamo emikhulu yokwakha iqembu elingcono kuzo zonke izici kusukela ohlelweni lokuqeqesha kanye nohlelo lokuhlola kuya ohlelweni lwethalente.
U-Deebio uphinde wenza inqubekelaphambili entsha ezifundweni nasezimakethe.NgokukaZhang Ge, u-Deebio ufaka isicelo sokuthola isitifiketi se-US FDA kanye nesitifiketi se-PMDA saseJapan.Kulo nyaka, bazoqhubeka nokuthuthukisa imakethe yaseJapan kanye ne-Tohri & Company Ltd yase-Japan.
“Ukunaka okulinganayo kukaDeebio kwezinguquko nokuthuthukiswa kwezimboni kuyathinta.Futhi kube negalelo ekuthuthukisweni kwemithi yezwe lethu kanye namalungiselelo e-enzyme,” kusho u-Yu Rong, uMqondisi woMnyango we-Biotechnology and Pharmacology we-West China School of Pharmacy, eNyuvesi yaseSichuan.
U-Deebio ufana nesazi esizinikele ocwaningweni lwaso.Ungumuntu ophansi, une-pragmatic futhi akaziphakamisi.Uwine imakethe yomhlaba wonke ngamandla akhe futhi wazuza ukunconywa nokuhlonishwa ngaphakathi nangaphandle kwemboni.
Ithonywe ubhubhane lomhlaba wonke, ikusasa lokuthunyelwa kwe-API yaseChina liyathembisa.Futhi ngenxa yenguquko eqhubekayo "yohlangothi lokunikezela" ekhuthazwa ukuvikelwa kwemvelo, ukuhlolwa okufanayo nezinqubomgomo zokubuyekeza ezihlobene, ama-API angase angene enkathini entsha yentuthuko.Emkhankasweni othi “I-Enzyme Engcono Impilo Engcono”, u-Deebio uvumele umhlaba ukuthi ube ngofakazi wamandla okukhiqizwa kwe-bio-enzyme yaseChina ngokusebenza kwayo okuvelele.Ngokuzayo, u-Deebio uzophinde abambe amathuba ezikhathi futhi aholele imboni ezingeni elisha.
Othintana naye Abezindaba:
Umuntu Othintwayo: Selina Liu
I-imeyili:selina@deebio.com
Iwebhusayithi:http://www.deebiotech.com/
UMTHOMBO: Sichuan Deebiotech Corp., Ltd.
Buka inguqulo yomthombo ku-accesswire.com:
Isikhathi sokuthumela: Aug-20-2021
